Sign up for our complimentary
weekly e-journal

Main Newsletter
Mastery Series
Therapy Series
Bookmark and Share | Print Article | Did You Know Previous | All Articles This Week | Next
This article originally posted and appeared in  MedicationIssue 600

Rosiglitazone Restricted to Mail

Diabetes drugs with rosiglitazone are now available only through certified mail-order pharmacies. Doctors wishing to prescribe the drugs and patients planning to continue taking them should enroll in GlaxoSmithKline's Avandia Rosiglitazone Medicines Access Program. As of November 18, Avandia (rosiglitazone maleate), Avandamet (rosiglitazone maleate and metformin hydrochloride), and Avandaryl (rosiglitazone maleate and glimepiride) will no longer be available from retail pharmacies. Last year, the FDA insisted that GSK implement a stringent restricted-access program for the drugs after a meta-analysis of 52 studies showed that the drug is associated with a significantly increased risk of MI. The restricted-access program confines rosiglitazone prescriptions to patients who failed to control their blood glucose levels with other drugs and have decided, in consultation with their doctor, not to take pioglitazone.



Bookmark and Share | Print | Category | Home

This article originally posted 18 November, 2011 and appeared in  MedicationIssue 600

Past five issues: SGLT-2 Inhibitors Special Edition May 2015 | Diabetes Clinical Mastery Series Issue 242 | Issue 782 | GLP-1 Special Editions May 2015 | Diabetes Clinical Mastery Series Issue 241 |

Cast Your Vote
Do you believe that the FDA takes too much time to approve a drug?
CME/CE of the Week
Category: Nutrition
Credits: 0.5
Search Articles On Diabetes In Control